103668-99-1 Usage
Description
3-(2-Thienyl)benzaldehyde, also known as thiophene-2-carboxaldehyde, is a chemical compound characterized by its molecular formula C11H8OS. It presents itself as a yellow liquid with a distinctive strong and pungent odor. 3-(2-Thienyl)benzaldehyde is recognized for its diverse applications across various industries, including its use as a flavoring agent, fragrance ingredient, and intermediate in the synthesis of pharmaceuticals and other organic compounds. Furthermore, 3-(2-Thienyl)benzaldehyde has garnered interest for its potential biological and pharmacological properties, suggesting its utility in medicinal and healthcare products.
Uses
Used in the Food Industry:
3-(2-Thienyl)benzaldehyde is used as a flavoring agent for its distinctive aromatic properties, enhancing the sensory experience of food products.
Used in the Perfume Industry:
In the realm of perfumery, 3-(2-Thienyl)benzaldehyde serves as a fragrance ingredient, contributing to the creation of complex and appealing scents in perfumes and other fragranced products.
Used in Pharmaceutical Synthesis:
3-(2-Thienyl)benzaldehyde is utilized as an intermediate in the synthesis of various pharmaceuticals, playing a crucial role in the development of new medications.
Used in Organic Compound Synthesis:
3-(2-Thienyl)benzaldehyde also acts as an intermediate in the synthesis of other organic compounds, broadening its applications in the field of organic chemistry.
Used in Medicinal and Healthcare Products:
3-(2-Thienyl)benzaldehyde has been studied for its potential biological and pharmacological properties, indicating its possible use in the development of medicinal and healthcare products, although further research is necessary to fully explore these applications.
Check Digit Verification of cas no
The CAS Registry Mumber 103668-99-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,6,6 and 8 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 103668-99:
(8*1)+(7*0)+(6*3)+(5*6)+(4*6)+(3*8)+(2*9)+(1*9)=131
131 % 10 = 1
So 103668-99-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H8OS/c12-8-9-3-1-4-10(7-9)11-5-2-6-13-11/h1-8H
103668-99-1Relevant articles and documents
Generation of aryl radicals from arylboronic acids by manganese(III) acetate: Synthesis of biaryls and heterobiaryls
Demir, Ayhan S.,Reis, Oemer,Emrullahoglu, Mustafa
, p. 578 - 580 (2003)
The efficient generation of aryl radicals from arylboronic acids by manganese(III) acetate is described. In aromatic solvents, in situ generated aryl radicals afford the corresponding biaryls in very good yields. This method works selectively, and yields
New Steroidal 4-Aminoquinolines Antagonize Botulinum Neurotoxin Serotype A in Mouse Embryonic Stem Cell Derived Motor Neurons in Postintoxication Model
Konstantinovi?, Jelena,Kiris, Erkan,Kota, Krishna P.,Kugelman-Tonos, Johanny,Videnovi?, Milica,Cazares, Lisa H.,Terzi? Jovanovi?, Nata?a,Verbi?, Tatjana ?.,Andjelkovi?, Boban,Duplantier, Allen J.,Bavari, Sina,?olaja, Bogdan A.
, p. 1595 - 1608 (2018)
The synthesis and inhibitory potencies against botulinum neurotoxin serotype A light chain (BoNT/A LC) using in vitro HPLC based enzymatic assay for various steroidal, benzothiophene, thiophene, and adamantane 4-aminoquinoline derivatives are described. In addition, the compounds were evaluated for the activity against BoNT/A holotoxin in mouse embryonic stem cell derived motor neurons. Steroidal derivative 16 showed remarkable protection (up to 89% of uncleaved SNAP-25) even when administered 30 min postintoxication. This appears to be the first example of LC inhibitors antagonizing BoNT intoxication in mouse embryonic stem cell derived motor neurons (mES-MNs) in a postexposure model. Oral administration of 16 was well tolerated in the mouse up to 600 mg/kg, q.d. Although adequate unbound drug levels were not achieved at this dose, the favorable in vitro ADMET results strongly support further work in this series.
Propionic Acid Derivatives and Methods of Use Thereof
-
Paragraph 1794; 1795, (2018/11/21)
Provided herein are compounds and pharmaceutical compositions of formula I where R1, R2, R3, R4, R5 and R6 are as described herein. Also provided pharmaceutically acceptable salts or stereoisomers of these compounds. In addition methods are provided for inhibiting the binding of an integrin to treat various pathophysiological conditions.
